Michael Thomas Heffernan Akebia Therapeutics, Inc. (AKBA) insider trading activity

Michael Thomas Heffernan is of Akebia Therapeutics, Inc.. Currently has a direct ownership of 48,586 shares of AKBA, which is worth approximately $66,562. The most recent transaction as insider was on Jun 02, 2021, when has been sold 13,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.6K

0% 3M change

0% 12M change

Total Value Held $66,562

Michael Thomas Heffernan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 02 2021	BUY Grant, award, or other acquisition	-	13,700 Added 22.0%	48,586 Common Stock

Also insider at

SYBX

SYNLOGIC, INC. Healthcare

COLL

COLLEGIUM PHARMACEUTICAL, INC Healthcare

Director

BHVN

Biohaven Pharmaceutical Holding Co Ltd. Healthcare

TRVI

Trevi Therapeutics, Inc. Healthcare

BHVN

Biohaven Ltd.

MTH